A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Hematology Oncology Consultants
Study ID
NCT00159094
Phase
PHASE2
Status
Unknown

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is a phase II trial of Doxil on day 1 and vinorelbine on days 1 and 2 in women with metastatic breast cancer. Administered every 28 days. A study to assess the safety and efficacy of Doxil and vinorelbine in metastatic breast cancer.

Key Dates

Start date
Oct 31, 2003
Status verified
Sep 2005

Study Design

Enrollment
30 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Response rate

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Hematology Oncology Consultants, IncColumbusOhio43235
Debbie Conover, RN
[email protected]
614-846-0044
Leslie R Laufman, MD (PRINCIPAL_INVESTIGATOR)
Harris Spiridonidis, MD (SUB_INVESTIGATOR)
Sanjay Yadav, MD (SUB_INVESTIGATOR)
Hematology Oncology Consultants, IncNewarkOhio43055
Heather Meek
[email protected]
740-344-5705
Leslie R Laufman, MD (PRINCIPAL_INVESTIGATOR)
Harris Spiridonidis, MD (SUB_INVESTIGATOR)
Sanjay Yadav, MD (SUB_INVESTIGATOR)

Find similar trials in Columbus, OH

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Hematology Oncology Consultants, Inc· Columbus, OHHematology Oncology Consultants, Inc· Newark, OH

Related Studies